Rybelsus (semaglutide) is a brand-name prescription medication that’s FDA-approved to treat type 2 diabetes. The drug helps control blood sugar in adults when used with diet and exercise. Semaglutide is a diabetic medication (and not insulin) that diabetics would use to help manage their blood glucose. This type of medication is usually added on to regular diabetic treatments (such as insulin pens, cartridges, vials and use of insulin plants).
If diet and exercise aren’t helping you manage your type 2 diabetes, Rybelsus shouldn’t be the first medication that you try. Rybelsus isn’t approved to treat type 1 diabetes or a complication of diabetes called diabetic ketoacidosis.
A study has shown that Rybelsus helps lower blood sugar more than a placebo (treatment with no active drug). Researchers used blood tests to measure the level of hemoglobin A1c (HbA1c), which is a marker of blood sugar control. Target values of 7% are common for HbA1c, but this varies from person to person. Talk with your doctor about the target goal for your treatment. Rybelsus is used similarly to Ozempic (2mg and 4mg) and Trulicity and has become more common for weight-loss enthusiasts.
Ensure you are open with your dialogue with your doctor about medications you are currently on. As semaglutide may not combine well with other medications (such as Jardiance).
In the 26-week study of adults with type 2 diabetes, those who took Rybelsus had a decrease in their HbA1c level of 1.2% to 1.4%. This was compared with a decrease of only 0.3% in people who took a placebo. At the end of the study, about 69% to 77% of people who took Rybelsus had an HbA1c level of less than 7%, compared with 31% of those who took a placebo.
Although, Rybelsus and Ozempic have similar properties, they do have their differences and your doctor would be able to prescribe which one is best for you.